Form 4: Avanos Medical Executive Woody Reports Share Transactions Following RSU Vesting
SEC Form 4 Filing
Former Avanos Medical CEO Joseph Fralin Woody reports the vesting of restricted share units and subsequent transactions to cover tax obligations.
Summary
- On March 4, 2025, Joseph Fralin Woody, former CEO of Avanos Medical, had performance-based restricted share units (PRSUs) vest, representing 32,158 shares of common stock.
- Following the vesting, shares were surrendered to the issuer to satisfy tax withholding obligations related to both the vested PRSUs (10,167 shares) and time-based restricted share units (TRSUs) (8,184 shares) that also vested on the same date.
- Woody also acquired 1,000 shares on June 30, 2024, under the Issuer's Employee Stock Purchase Plan.
- After these transactions, Woody directly owns 434,852 shares of Avanos Medical common stock.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting standard executive compensation practices and regulatory reporting.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a standard practice for executives holding company stock and equity-based compensation.
Key Dates
| Date | Description |
|---|---|
| 03/04/2022 | Date PRSUs and TRSUs were awarded to the Reporting Person |
| 06/30/2024 | Date of share acquisition under the Employee Stock Purchase Plan |
| 03/04/2025 | Date of vesting of PRSUs and TRSUs, and subsequent share surrender for tax obligations |
| 03/06/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.